체외수정 기기 및 소모품 시장 : 제품 유형, 기술 유형, 최종사용자별 - 세계 예측(2025-2030년)

The IVF Devices & Consumables Market was valued at USD 2.85 billion in 2023, expected to reach USD 3.35 billion in 2024, and is projected to grow at a CAGR of 17.64%, to USD 8.91 billion by 2030.

The scope of the IVF Devices & Consumables market encompasses a comprehensive suite of tools and consumables designed for assistance in the in-vitro fertilization process, including culture media, incubators, cryosystems, and other laboratory equipment. This market segment is driven by the increasing prevalence of infertility, advancements in healthcare technologies, and rising awareness regarding assisted reproductive techniques. IVF devices are essential in laboratory fertilization processes, while consumables ensure the optimal handling and storage of embryos and gametes. The primary application of these devices is within fertility clinics and hospitals, with notable end-use demographics including couples facing infertility and individuals opting for elective pregnancies. Key growth influencers include technological advancements in IVF procedures, improved success rates due to innovative devices, and supportive government initiatives encouraging treatment accessibility. Emerging opportunities can be found within the development of more cost-efficient technologies making IVF more accessible to broader populations, and integrating AI-driven solutions for better embryo assessment. However, factors such as high procedural costs, ethical concerns, and stringent regulatory frameworks pose challenges to market growth. Potential innovations could focus on enhancing the precision of gamete manipulation tech, personalization in IVF treatments using genomics, and improving automation to reduce procedural costs. Furthermore, research into cryopreservation techniques and non-invasive monitoring tools for embryos could provide critical growth avenues. Despite current limitations, continuous advancements in medical technology and genetics are expected to steer the market towards robust growth. The nature of the IVF Devices & Consumables market is highly competitive and technology-driven, requiring continuous innovation and strategic alliances for businesses to thrive. Companies should invest in R&D, collaborate with fertility centers, and focus on geographic expansions into underpenetrated markets to capitalize on burgeoning opportunities and address market challenges effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving IVF Devices & Consumables Market

The IVF Devices & Consumables Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of infertility rates globally and the need for effective IVF procedures
  • Supportive government incentives and subsidies for fertility treatments worldwide
• Market Restraints
  • Expensive and complex IVF procedures and Limited Insurance Coverage for IVF Treatments
• Market Opportunities
  • Innovations in imaging technologies and embryo monitoring systems for IVF procedures
  • Rise of venture capital in IVF technology startups for enhanced research and development
• Market Challenges
  • Product recalls and limited standardization in IVF devices

Porter's Five Forces: A Strategic Tool for Navigating the IVF Devices & Consumables Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the IVF Devices & Consumables Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the IVF Devices & Consumables Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the IVF Devices & Consumables Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the IVF Devices & Consumables Market

A detailed market share analysis in the IVF Devices & Consumables Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the IVF Devices & Consumables Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the IVF Devices & Consumables Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the IVF Devices & Consumables Market

A strategic analysis of the IVF Devices & Consumables Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the IVF Devices & Consumables Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Astec Co., Ltd., Becton, Dickinson and Company, Biopsybell S.R.L., DSS Imagetech Pvt. Ltd., Eppendorf SE, Esco Micro Pte. Ltd., Fujifilm Irvine Scientific, Inc., Genea Biomedx Pty Ltd., Gynotec B.V., Hamilton Thorne Inc. by Hamilton Thorne Ltd. Group, Hunter Scientific Limited, Kitazato Corporation, LABOTECT GmbH, LABOX, spol. s r.o., Manina Medtech S.L., Merck KGaA, Nidacon International AB, Overture Life, PHC Holdings Corporation, Rocket Medical PLC by Roko, Shivani Scientific Industries Pvt. Ltd., Smiths Group PLC, The Cooper Companies, Inc., Thermo Fisher Scientific Inc., and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the IVF Devices & Consumables Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Accessories & Disposables, Instruments, and Reagents & Media. The Instruments is further studied across Cabinets, Cryosystems, Imaging Systems, Incubators, Micromanipulator, Ovum Aspiration Pump, and Sperm Separation Systems.
• Based on Technology Type, market is studied across Donor Egg IVF, Fresh Embryo IVF, and Frozen Embryo IVF.
• Based on End User, market is studied across Cryobanks, Fertility Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of infertility rates globally and the need for effective IVF procedures
    • 5.1.1.2. Supportive government incentives and subsidies for fertility treatments worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. Expensive and complex IVF procedures and Limited Insurance Coverage for IVF Treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations in imaging technologies and embryo monitoring systems for IVF procedures
    • 5.1.3.2. Rise of venture capital in IVF technology startups for enhanced research and development
  • 5.1.4. Challenges
    • 5.1.4.1. Product recalls and limited standardization in IVF devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Utilization of consumables & precision instruments in IVF procedures to protect fragile biological materials
  • 5.2.2. Technology Type: Increasing need for frozen embryo IVF to align with personal health, timing, and financial considerations
  • 5.2.3. End User: Extensive usage of IVF devices & consumables in cryobanks to ensure the long-term viability of reproductive materials
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. IVF Devices & Consumables Market, by Product

• 6.1. Introduction
• 6.2. Accessories & Disposables
• 6.3. Instruments
  • 6.3.1. Cabinets
  • 6.3.2. Cryosystems
  • 6.3.3. Imaging Systems
  • 6.3.4. Incubators
  • 6.3.5. Micromanipulator
  • 6.3.6. Ovum Aspiration Pump
  • 6.3.7. Sperm Separation Systems
• 6.4. Reagents & Media

7. IVF Devices & Consumables Market, by Technology Type

• 7.1. Introduction
• 7.2. Donor Egg IVF
• 7.3. Fresh Embryo IVF
• 7.4. Frozen Embryo IVF

8. IVF Devices & Consumables Market, by End User

• 8.1. Introduction
• 8.2. Cryobanks
• 8.3. Fertility Clinics
• 8.4. Hospitals

9. Americas IVF Devices & Consumables Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific IVF Devices & Consumables Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa IVF Devices & Consumables Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Vitrolife AB Enhances IVF Clinical Management through Strategic Acquisition of eFertility
  • 12.3.2. Pioneering Partnership in IVF Technology: GenEmbryomics Joins Forces with Progenesis for Advanced Embryo Screening
  • 12.3.3. Advancements in IVF Storage Solutions: Introducing TMRW's CryoLink for Enhanced Digital Specimen Management
  • 12.3.4. Pioneering AI Integration in IVF: Alife Health Partners with Boston IVF to Optimize Treatment Outcomes
  • 12.3.5. Innovative Leap in IVF Technology: Manina Medtech's SEEDCHRONY Enhances Embryo Implantation Success
  • 12.3.6. Empowering Women in India through Innovative At-Home Fertility Testing
  • 12.3.7. Advances in IVF Technology: Orchid's Launch of Whole Genome Sequencing for Embryos
  • 12.3.8. Bea Fertility Secures Investment from Pioneer Group to Enhance At-Home Fertility Solutions and Pursue U.S. Expansion
  • 12.3.9. Strategic Merger Between INVO Bioscience and NAYA Biosciences to Enhance Life Science Innovations
  • 12.3.10. Strategic Integration Enhances IVF Success: Future Fertility and Genea Biomedx Collaborate on Advanced Oocyte Assessment
  • 12.3.11. Thermo Fisher Scientific Expands Reproductive Health Research Capabilities with New Assays
  • 12.3.12. Advancements in IVF Technology: FUJIFILM Irvine Scientific Introduces Genetics Module to Enhance Embryo Selection
  • 12.3.13. Innovative Integration in IVF Technology: AIVF and Genea Biomedx Form Strategic Alliance
• 12.4. Strategy Analysis & Recommendation
  • 12.4.1. The Cooper Companies, Inc.
  • 12.4.2. Hamilton Thorne Inc. by Hamilton Thorne Ltd. Group
  • 12.4.3. PHC Holdings Corporation
  • 12.4.4. Esco Micro Pte. Ltd.
  • 12.4.5. Genea Biomedx Pty Ltd.

Companies Mentioned

• 1. Advin Health Care
• 2. Astec Co., Ltd.
• 3. Becton, Dickinson and Company
• 4. Biopsybell S.R.L.
• 5. DSS Imagetech Pvt. Ltd.
• 6. Eppendorf SE
• 7. Esco Micro Pte. Ltd.
• 8. Fujifilm Irvine Scientific, Inc.
• 9. Genea Biomedx Pty Ltd.
• 10. Gynotec B.V.
• 11. Hamilton Thorne Inc. by Hamilton Thorne Ltd. Group
• 12. Hunter Scientific Limited
• 13. Kitazato Corporation
• 14. LABOTECT GmbH
• 15. LABOX, spol. s r.o.
• 16. Manina Medtech S.L.
• 17. Merck KGaA
• 18. Nidacon International AB
• 19. Overture Life
• 20. PHC Holdings Corporation
• 21. Rocket Medical PLC by Roko
• 22. Shivani Scientific Industries Pvt. Ltd.
• 23. Smiths Group PLC
• 24. The Cooper Companies, Inc.
• 25. Thermo Fisher Scientific Inc.
• 26. Vitrolife AB